The Enroll-HD Global Investigator Meeting was held in Dublin, Ireland on 21-23 June 2012.
CITY WEST HOTEL - DUBLIN
The meeting did offer investigators and research staff the opportunity to join other researchers from around the world to learn more about Enroll-HD. Investigators and Research Staff from both new and existing sites worldwide who have shown a committed interest in participating in the Enroll-HD Study were invited. --> Agenda

Scientific Publication Review Committee was elected during the meeting.

Click here for the presentations:
Friday - Saturday
Q&A European session

Written to keep you updated on the process of getting Enroll-HD up and running through-out the world. It is released quarterly.

Issue 6, Feb 2013 

Issue 5, Oct 2012 

Issue 4, May 2012 

Issue 3, Jan 2012 

Issue 2, Oct 2011 

Issue 1, Jul 2011 

1. Enroll-HD is a global longitudinal, observational study of Huntington’s disease
2. Enroll-HD collects a common set of data for all participants across all sites around the world
3. Enroll-HD also collects blood samples for DNA and cell lines
4. All data and samples will be available to share with researchers to answer important questions about HD

Enroll-HD will help the research community by:

• Providing clinical data and biologic samples to help better understand the human biology of Huntington’s disease – there is still a lot we don’t know
• Determining what interventions work to improve the care of people with HD
• Developing better, smarter clinical trials
• Promoting the recruitment of clinical trial participants

FIRST 500 Participants!

On April 4, 2013 sites in North America enrolled the first 500 Participants into Enroll-HD. Since we first announced Enroll-HD in November 2010 we have made great progress in establishing this important research platform for HD research. 

Enroll-HD Goals

To add information about your study site to the Global Site & Investigator Feasibility Questionnaire on Huntington's Disease please visit the GSID website